Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 2

1(25.0%)

4Total

N/A(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06310356Not ApplicableRecruiting

Continuous Glucose Monitoring for Women With Gestational Diabetes

Role: collaborator

NCT05329883Recruiting

Multicentric Study on Infections of the Urinary Tract After Stent Removal (MINUS-trial).

Role: collaborator

NCT05903105Not Yet Recruiting

Diversity in Patients With OAB

Role: collaborator

NCT04938336Completed

Evaluation of a Decision Aid Tool in Rectal Cancer patiënts

Role: collaborator

NCT01350466Completed

Prospective Study Investigating the Role of Occupational Exposure on Sinus Surgery Outcome

Role: collaborator

NCT04632511Not ApplicableActive Not Recruiting

Metabotyping of Overweight and Obese Children

Role: collaborator

NCT03511391Phase 2Completed

CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors

Role: collaborator

NCT05183269Not ApplicableCompleted

Virtual Reality for Pain Control During Extracorporeal Shock Wave Lithotripsy: a Prospective, Comparative, Randomized Study at a Single Institution

Role: lead

NCT04896879Completed

Experiences and Needs of Patients, Their Informal Caregiver and Healthcare Professionals Regarding LARS

Role: collaborator

NCT04473027Terminated

BLood Groups as Biomarker to Optimize Odds of Response to Anti-PD-1 Drugs

Role: collaborator

All 10 trials loaded